1. In vitro activity of doripenem (S-4661) against multidrug-resistant Gram-negative bacilli isolated from patients with cystic fibrosis;Chen;Antimicrob. Agents Chemother.,2005
2. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard—7th edition, M7-A7;Clinical and Laboratory Standards Institute (CLSI),2006
3. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria, M45-A;Clinical and Laboratory Standards Institute (CLSI),2006
4. Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement, M100-S18;Clinical and Laboratory Standards Institute (CLSI),2008
5. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil;Dalla-Costa;J. Clin. Microbiol.,2003